Physician profile
Pothen Jacob
NPI 1467423004
$1,021.29
in general payments reported to CMS, 2019-2025
11 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $531 · 2020: $113 · 2022: $102 · 2023: $210 · 2024: $64.75.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $275.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $275.10 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $536.13 | 2019-2024 | |
| Takeda Pharmaceuticals U.S.A., INC. | $131.73 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $85.18 | 2019-2020 | |
| Janssen Biotech, INC. | $58.06 | 2019-2020 | |
| Gilead Sciences, INC. | $55.52 | 2019-2020 | |
| Allergan, INC. | $42.18 | 2019 | |
| Daiichi Sankyo INC. | $26.33 | 2022 | |
| Apollo Endosurgery US INC | $26.13 | 2020 | |
| Intercept Pharmaceuticals, INC. | $25.07 | 2022 | |
| Lucid Diagnostics INC. | $20.69 | 2023 | |
| Alnylam Pharmaceuticals INC. | $14.27 | 2024 | Givlaari |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Pothen Jacob listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.